Digestive, hepatic, and nutritional manifestations in Latin American children with HIV/AIDS

Carlos Alberto Velasco-Benítez1

  • 1Department of Pediatrics, University of Valle, Cali, Colombia. cvelasco@univalle.edu.co

Insights

The Human Immunodeficiency Virus (HIV) infection is rising in Latin America, driven by factors like poverty and limited access to antiretroviral drugs. Pediatric cases primarily result from perinatal transmission, highlighting the need for better understanding and care.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • The Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) epidemic is growing in Latin America and the Caribbean.
  • Key contributing factors include poverty, restricted access to antiretroviral drugs, inadequate governmental response, migration, and limited research funding.
  • Perinatal transmission is the predominant route of HIV infection in the pediatric population within this region.

Purpose of the Study:

  • To highlight the increasing prevalence of HIV/AIDS in Latin America.
  • To identify the primary causes and transmission routes of HIV in the region, particularly in children.
  • To emphasize the need for enhanced knowledge and management strategies for HIV-related conditions in pediatric patients.

Main Methods:

  • Review of World Health Organization (WHO) data on HIV/AIDS trends.
  • Analysis of contributing factors to HIV spread in Latin America.
  • Classification of pediatric HIV infection based on Centers for Disease Control and Prevention (CDC) criteria for digestive, hepatic, and nutritional manifestations.

Main Results:

  • HIV/AIDS incidence is increasing across Latin America and the Caribbean.
  • Brazil, Mexico, and Colombia report the highest number of cases in Latin America.
  • Digestive, hepatic, and nutritional issues are key indicators for classifying pediatric HIV infection.

Conclusions:

  • Further research and improved understanding of HIV enteropathy, pathogenesis, and physiopathology are crucial.
  • Enhanced nutritional care practices for children with HIV are recommended.
  • Addressing socioeconomic factors and improving healthcare infrastructure are vital for controlling the HIV epidemic in the region.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...